- Home
- FCEL vs ABSI Comparison
FCEL vs ABSI Comparison
Compare FCEL & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCEL | ABSI |
|---|---|---|
| Founded | 1969 | 2011 |
| Country | United States | United States |
| Employees | 629 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 997.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FCEL | ABSI |
|---|---|---|
| Price | $21.37 | $7.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.31 | $6.96 |
| AVG Volume (30 Days) | ★ 12.3M | 4.3M |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $4.77 | $215.96 |
| Revenue Next Year | $42.46 | $319.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.78 | $2.24 |
| 52 Week High | $37.88 | $12.06 |
Technical Indicators
Market Signals| Indicator | FCEL | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 39.24 |
| Support Level | $16.66 | $2.56 |
| Resistance Level | $27.69 | $12.06 |
| Average True Range (ATR) | 2.45 | 0.72 |
| MACD | -0.22 | -0.44 |
| Stochastic Oscillator | 56.23 | 3.79 |
Price Performance
Historical ComparisonAbout FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.